In the BioHarmony Drug Report Database
Nicardipine
Cardene, Cardene Sr, Nicardipine (nicardipine) is a small molecule pharmaceutical. Nicardipine was first approved as Cardene on 1988-12-21. It is used to treat hypertension, stable angina, and variant angina pectoris in the USA. It is known to target adenosine receptor A3 and potassium voltage-gated channel subfamily A member 4. Cardene iv’s patents are valid until 2027-12-26 (FDA).
Trade Name
|
Cardene, Cardene In Dextrose, Cardene Sr, Nicardipine |
---|---|
Common Name
|
nicardipine |
ChEMBL ID
|
CHEMBL1484 |
Indication
|
hypertension, stable angina, variant angina pectoris |
Drug Class
|
Phenylpyridine vasodilators (nifedipine type) |
Image (chem structure or protein)